According to NICE Technology Appraisal 875, Wegovy is recommended for use within the NHS for adults with a BMI of at least 35 kg/m and at least one weight-related comorbidity, or a BMI of at least 30 kg/m with type 2 diabetes, when provided through specialist weight management services
Most women begin noticing appetite changes within 3 to 4 weeks and see meaningful weight loss results by week 12
A patient with BMI 35 or higher would also meet Tier 1 by BMI alone, which is simpler to document
If youre confused about what clear liquids are, youre not alone
PubMed laboratory research record [PMID: 18787032] PubMed record related to this compound for laboratory literature review
Different drugs performed better in different areas, but all 15 GLP-1RAs they analyzed were very successful in lowering blood glucose and achieving weight loss